中東およびアフリカの医薬品アイソレータ市場 – 業界動向と2029年までの予測

中東およびアフリカの医薬品アイソレータ市場の分析と洞察

製薬アイソレータは、製薬業界で汚染のないバリアシステムとして使用されています。微生物学的検査、細胞療法処理、先進医薬品（ATMP）製造、滅菌注射剤の計量、包装、配送は、製薬アイソレータのほんの一例です。製薬アイソレータの使用は、発展途上国と先進国の製薬市場の継続的な成長と、革新的な治療法を生み出すための研究開発費の増加によって促進されています。先進的な医療用絶縁体と製薬業界の要件により、大手メーカーは医療用絶縁体業界を成長させています。予測期間中、有害化合物の使用の増加、非準拠のコストの増加、研究室の増加は、製薬アイソレータ市場を牽引する重要な要因です。

しかし、ほとんどの専門家は、規制当局がもはや医薬品絶縁体の開発などの画期的な進歩の妨げにはならないという意見には反対している。

Data Bridge Market Research は、中東およびアフリカの医薬品アイソレータ市場は、予測期間中に 12.0% の CAGR で成長し、2029 年までに 2 億 3,279 万米ドルに達すると予測しています。中東およびアフリカの医薬品アイソレータの需要が急増しているため、タイプは市場で最大のタイプ セグメントを占めています。この市場レポートでは、価格分析、特許分析、技術進歩についても詳細に取り上げています。

中東およびアフリカの医薬品アイソレータ市場の定義

隔離の概念は、環境を保護しながら、プロセスをオペレータから、またはオペレータをプロセスから保護します。封じ込めの鍵は、最小限の暴露です。暴露範囲を化合物に設定された危険レベル以下に制御することにより、オペレータと環境が適切に保護されます。したがって、製品が保護され、重要な規制問題に対処します。製薬アイソレータは、無菌充填および有毒プロセスのために製薬環境で使用される密閉された細菌囲いです。完全に無菌のメインアイソレータで構成され、壁の1つに配置された肩の高さの手袋を使用して製品が取り扱われ、保管または梱包されます。製薬アイソレータは、製薬プロセスの制御と封じ込めを可能にします。製薬アイソレータの動作に必要な条件は、無菌環境であり、生存可能な微生物が存在しないことです。製薬アイソレータは、製造エリアと無菌環境が別々の位置に配置されることを保証します。製薬業界のアイソレータは、無菌環境の製薬業界のクリーンルームと比較して、費用対効果が高く効率的です。アイソレーターやアクセス制限バリアに求められるさまざまな認証基準に適応することで、微生物および医薬品製造プロセス中に制御された雰囲気を作り出します。同時に、製品、オペレーター、環境の保護を保証します。

医薬品アイソレータの豊富な用途は、生産と管理の目的によって異なります。固体、半固体、または粉末の医薬品の取り扱い、転送、梱包、溶液や輸液の取り扱いとファイリングに使用されます。医薬品アイソレータは、無菌試験、組織または生物学的生産システムまたは病原性サンプルの無菌取り扱いなどに適用されます。医薬品や医薬品の生産と管理に使用できます。製薬およびバイオテクノロジー業界全体でのアイソレータの需要の急増、低い運用コスト、医薬品の生産における無菌状態の高度な維持、およびバイオ医薬品業界の需要の増加は、予測期間中に市場の成長を促進すると予想される要因です。

また、市場プレーヤーによる戦略的取り組み、医薬品アイソレータの技術的進歩、高度な無菌性の保証、医療インフラへの投資の増加など、これらの要因により医薬品アイソレータ市場の需要が増加しています。

中東およびアフリカの医薬品アイソレータ市場の動向

このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。    

ドライバー

急成長する製薬業界における医薬品アイソレーターの需要増加

Pharmaceutical isolator is a separative device that divides a pharmaceutical procedure or activity from the operator and the adjacent environment. It is used for various purposes such as:

• Providing a categorized aseptic environment for an activity or procedure and guarding it from microbial and non-microbial contamination rising from the operator and adjacent environment which is referred to product protection.
• Protective product from contamination produced by other product and procedure, moreover at the same time or during earlier operations. This is referred to as safeguard against method generated contamination or cross- contamination.

The Increasing contamination problems in the manufacturing unit in which comes isolator that create a demand for Pharmaceutical isolator that helps in contamination and de-contamination.

• Low operational cost of pharmaceutical isolators

Enclosures that are sealed to some standard of leak tightness that comprises inside qualified controlled environment, at modification with the surrounding conditions isolator application reaches from R&D by the production of pharmaceuticals to laboratory use, especially for the microbiological quality control. Whereas pharmaceutical aseptic production has extremely high standards of cleanness almost completely particle free and germ free environments for the aseptic production.

Due to growth in the pharma industry and the widening product range more and more manufacturers and suppliers needs to think about investments in latest added technologies of the clean room technology.

Aseptic processing of the pharmaceutical drugs is the major factor need to be included in good manufacturing practices meeting the government regulations. The high cost of the maintenance of the aseptic condition by clean room technology which is around 62% higher than the pharmaceutical isolators, shifting the manufacturers to acquire isolator’s technology and constraining the overall manufacturing cost of the pharmaceutical products.

Restraint

• Stringent Governmental Regulations               

Active Pharmaceutical Ingredients (API) and intermediates for pharmaceutical use (for instance biological, radiopharmaceutical, and pharmaceutical) and those used to production drugs for clinical trials are regulated under the Divisions 1A and 2, Part C of the Food and Drug Regulations.

• Division 1A, Part C of the Food and Drug Regulations describes activities for which Good Manufacturing Practices (GMP) compliance is required and must be demonstrated prior to the issuance of an API establishment license (EL).
• Division 2, Part C of the Food and Drug Regulations defines the requirements for the GMP of APIs and API intermediates, which are interpreted in the present guidance document.

Due to this strict regulation by the government that has to be followed for the production by the Good Manufacturing Practices (GMP) Guidelines for Active Pharmaceutical Ingredients (API) - (GUI-0104) which constraining the market growth rate.

Opportunity

• Strategic initiatives by market players

The rise in the pharmaceutical isolators market increases the need for strategic business ideas. It includes a partnership, business expansion, and other development. The rising demand for pharmaceuticals is significantly increasing the demand for excipient and to cope with this demand companies are building new manufacturing sites among other strategic initiatives.

These strategic initiatives such as product launches, agreement and business expansion by the major market player will boost the pharmaceutical isolator market growth and is expected to act as an opportunity for the Middle East & Africa medical display market.

Challenge

Lack of skilled expertise

The shortage of skilled expertise would challenge the pace of recovery and growth in one place. Often, the people who are unemployed in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to lack of expertise.

Lack of skilled professionals while handling the pharmaceutical isolators poses a major challenge while selecting and developing the pharmaceutical isolators. The data by the Phys.org 2003 mentions the medical display industries are facing a shortage of workers due to increase demand of pharmaceutical isolators in Asia-Pacific region and severe scarcity of micro chips used in LED and LCD display, which increases the price lead times of LCD production.

As skill demands are too high, it has manifested as a challenge to retain and manage skill-specified professionals. Moreover, technological advancement is another aspect that leads to the increased demand for skilled professionals. Neurologists report significant unmet supportive care needs and barriers in their centers with only a small minority rating themselves as competently providing supportive care. There is an urgent need for education of neurologists and professionals for treatment of dementia and procuring available supportive care resources. Lack of trained and experienced professionals and persistent skill gaps limit the employability prospects and access to quality jobs. It is therefore apparent that availability of professionals equipped with adequate skills is expected to challenge the market growth.

Post-COVID-19 Impact on Middle East & Africa Pharmaceutical Isolator Market

The COVID-19 pandemic has become the world's most serious threat. It wreaked havoc in many stores and businesses around the world. The pandemic, on the other hand, has provided many opportunities for pharmaceutical and biopharmaceutical companies to expand their research and development activities to develop new vaccines against the new coronavirus. Companies are conducting clinical trials to try to stop the spread of the COVID-19 virus. Pharmaceutical insulator suppliers to biopharmaceutical organizations have more opportunities as the number of clinical trials increases.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launch and strategic partnerships to improve the technology and test results involved in the pharmaceutical medical display market.

Recent Developments

• In June 2022, the company announced a partnership with Medical Supply Company (MSC) to market and service Jacomex equipment to the pharmaceutical and pharmaceutical industries in Ireland. MSC has many years of recognized expertise in the market with field teams closest to customers and company’s commercial team currently working abroad had the pleasure of welcoming Cian Murphy and finalizing the agreement between Jacomex and MSC. The beginning of a long and fruitful collaboration. This has helped the company to expand their business.
• In January 2022, Clario partnered with XingImaging, a radiopharmaceutical production and positron emission tomography (PET) acquisition company, to deliver PET imaging clinical trials for testing novel therapeutics in China. The partnership offers to share the joint resources and neuroscience experts of Clario and XingImaging to expedite the startup of clinical trials and drug discovery in China.

Middle East & Africa Pharmaceutical isolator market Scope

Middle East & Africa pharmaceutical isolator market is segmented into type, pressure, application, configuration, system type, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

• ASEPTIC ISOLATORS
• CONTAINMENT ISOLATORS
• BIO ISOLATORS
• SAMPLING AND WEIGHING ISOLATORS
• ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
• RADIOPHARMACEUTICAL ISOLATORS
• PRODUCTION ISOLATORS
• OTHERS

On the basis of type, the Middle East & Africa pharmaceutical isolator market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators, radiopharmaceutical isolators, production isolators, others.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

• CLOSED SYSTEM
• OPEN SYSTEM

On the basis of system type, the Middle East & Africa pharmaceutical isolator market is segmented into closed system, open system.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE

• POSITIVE PRESSURE
• NEGATIVE PRESSURE

On the basis of pressure, the Middle East & Africa pharmaceutical isolator market is segmented into positive pressure and negative pressure.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

• FLOOR STANDING
• MODULAR
• MOBILE
• COMPACT
• TABLE TOP
• PORTABLE
• OTHERS

On the basis of configuration, the Middle East & Africa pharmaceutical isolator market is segmented into floor standing, modular, mobile, compact, table top, portable, others.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION

• STERILITY TESTING
• MANUFACTURING
• SAMPLING/ WEIGHING/ DISTRIBUTION
• MEDICAL DEVICE MANUFACTURING
• OTHERS

On the basis of application, the Middle East & Africa pharmaceutical isolator market is segmented into sterility testing, manufacturing, sampling/ weighing/ distribution, medical device manufacturing, others.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER

• HOSPITALS
• DIAGNOSTIC LABORATORIES
• ACADEMIC AND RESEARCH INSTITUTES
• PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
• CONTRACT RESEARCH ORGANIZATIONS
• OTHERS

On the basis of end user, the Middle East & Africa pharmaceutical isolator market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, others.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL

• DIRECT TENDER
• RETAIL SALES
• THIRD PARTY DISTRIBUTORS

On the basis of distribution channel, the Middle East & Africa pharmaceutical isolator market is segmented into direct tender, retail sales, third party distributors.

Middle East & Africa Pharmaceutical Isolator Market Regional Analysis/Insights

The Middle East & Africa pharmaceutical isolator market is analyzed and market size information is provided type, pressure, application, configuration, system type, end user and distribution channel.

The countries covered in this market report South Africa, Saudi Arabia, UAE, Egypt, Israel and rest of the Middle East and Africa.

In 2022, South Africa is dominating due to technological advancements in the pharmaceutical isolator and increases in the future of robotics technology in the pharmaceutical isolator industry

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East & Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Middle East & Africa Pharmaceutical Isolator Market Share Analysis

中東およびアフリカの医薬品アイソレータ市場の競争状況では、競合他社ごとに詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線が含まれます。提供されている上記のデータ ポイントは、中東およびアフリカの医薬品アイソレータ市場への会社の重点にのみ関連しています。

中東およびアフリカの医薬品アイソレータ市場で活動している主要企業には、Getinge、SKAN AG、Hosokawa micron ltd、Gelman Singapore、Azbil Corporation、Germfree Laboratories, Inc.、M. Braun Inertgas-Systeme Gmbh、Nuaire、Iteco SRL、Comecer SPA、Hecht Technologie Gmbh、Steriline SRL、Envair Limited、Tema Sinergie SPA、Schematic Engineering Industries、千代田化工建設、Chamunda Pharma Machinery Pvt. Ltd、Bioquell (Ecolab Solution)、Jacomex、Fedegari Autoclavi SpA、LAF Technologies、ISO Tech Design、Cytiva、Esco Pharma などがあります。

調査方法: 中東およびアフリカの医薬品アイソレーター市場

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。さらに、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これとは別に、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、中東およびアフリカと地域、ベンダー シェア分析が含まれます。さらに問い合わせる場合は、アナリストへの電話をリクエストしてください。

SKU-35231